Need help finding what you are looking for?
Contact Us
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1397198
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1397198
Bioanalytical Testing Services Market Size and Share Report by Molecule Type, Test Type, End User, Workflow - Global Industry Demand Forecast to 2030
PUBLISHED:
PAGES: 210 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The value of the bioanalytical testing services market is USD 3,456.6 million in 2023, and it will power at a rate of 15.9% by the end of this decade, to touch USD 9,652.6 million by 2030.
This is credited to the well-known life sciences industry using bioanalytical testing, the existence of main service providers, the increased count of continuing clinical trials, high R&D spending, and the development of biosimilar and generic markets.
The small molecule category held the largest share of 50%, in 2023, and will maintain its dominance in the years to come. This is for the reason that small molecules are traditional pharma, and naturally they have a low molecular weight of less than 900 Daltons and adjust a biological procedure.
Furthermore, numerous outsourcing companies are offering studies on numerous small molecules for example pharmacodynamic studies, pharmacokinetic studies, and assays of biomarkers.
Based on test type, the bioavailability category had the largest share, of 40%, in 2023, and it will also be like this in the years to come as well. This is because of the high requirement for these services in generic molecule expansion.
Furthermore, corporations are more focused on producing the finest effective therapeutic drugs with efficient drug moiety. Moreover, the increasing consumer concern pertaining to self-care is enhancing the consumption of pharma drugs, which, in line, considerably powers the requirement for bioavailability testing.
On the basis of end user, the pharma and biopharma companies' category had the largest revenue share, of 35%, in 2023, and this will maintain its dominance by the end of this decade.
This is for the reason that these companies are mostly focused on the advance of new drugs for treating various diseases, and are also more focused on the mass manufacturing of drugs as a result of the increasing incidence of diseases and numerous infectious cases.
So, the corporations are accepting outsourcing of the early-phase expansion of drug, lab, and clinical testing services to advance profit margins, evade high spending, and decrease time duration to authenticate the products and procedures.
North America bioanalytical testing services market was the leader of the pack of about 45%, in 2023, and the industry will experience a robust rate in the years to come.
This is because of the presence of numerous patients with chronic ailments, the increase in the acceptance of large molecule therapeutics and peptides, substantial growth in the pharma and biotech industries, and the existence of key service providers for the regional industry.
It is because of the growth in the count of ongoing clinical trials all over the world, the demand for bioanalytical testing services will continue to grow in the years to come as well.
Product Code: 12719
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by molecule type
- 1.4.2. Market size breakdown, by test type
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by workflow
- 1.4.5. Market size breakdown, by region
- 1.4.6. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Molecule Type (2017-2030)
- 6.3. Market Revenue, by Test Type (2017-2030)
- 6.4. Market Revenue, by End User (2017-2030)
- 6.5. Market Revenue, by Workflow (2017-2030)
- 6.5.1. Sample preparation market revenue, by type (2017-2030)
- 6.5.2. Sample analysis market revenue, by type (2017-2030)
- 6.6. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Molecule Type (2017-2030)
- 7.3. Market Revenue, by Test Type (2017-2030)
- 7.4. Market Revenue, by End User (2017-2030)
- 7.5. Market Revenue, by Workflow (2017-2030)
- 7.5.1. Sample preparation market revenue, by type (2017-2030)
- 7.5.2. Sample analysis market revenue, by type (2017-2030)
- 7.6. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Molecule Type (2017-2030)
- 8.3. Market Revenue, by Test Type (2017-2030)
- 8.4. Market Revenue, by End User (2017-2030)
- 8.5. Market Revenue, by Workflow (2017-2030)
- 8.5.1. Sample preparation market revenue, by type (2017-2030)
- 8.5.2. Sample analysis market revenue, by type (2017-2030)
- 8.6. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Molecule Type (2017-2030)
- 9.3. Market Revenue, by Test Type (2017-2030)
- 9.4. Market Revenue, by End User (2017-2030)
- 9.5. Market Revenue, by Workflow (2017-2030)
- 9.5.1. Sample preparation market revenue, by type (2017-2030)
- 9.5.2. Sample analysis market revenue, by type (2017-2030)
- 9.6. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Molecule Type (2017-2030)
- 10.3. Market Revenue, by Test Type (2017-2030)
- 10.4. Market Revenue, by End User (2017-2030)
- 10.5. Market Revenue, by Workflow (2017-2030)
- 10.5.1. Sample preparation market revenue, by type (2017-2030)
- 10.5.2. Sample analysis market revenue, by type (2017-2030)
- 10.6. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Molecule Type (2017-2030)
- 11.3. Market Revenue, by Test Type (2017-2030)
- 11.4. Market Revenue, by End User (2017-2030)
- 11.5. Market Revenue, by Workflow (2017-2030)
- 11.5.1. Sample preparation market revenue, by type (2017-2030)
- 11.5.2. Sample analysis market revenue, by type (2017-2030)
- 11.6. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Molecule Type (2017-2030)
- 12.3. Market Revenue, by Test Type (2017-2030)
- 12.4. Market Revenue, by End User (2017-2030)
- 12.5. Market Revenue, by Workflow (2017-2030)
- 12.5.1. Sample preparation market revenue, by type (2017-2030)
- 12.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Molecule Type (2017-2030)
- 13.3. Market Revenue, by Test Type (2017-2030)
- 13.4. Market Revenue, by End User (2017-2030)
- 13.5. Market Revenue, by Workflow (2017-2030)
- 13.5.1. Sample preparation market revenue, by type (2017-2030)
- 13.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Molecule Type (2017-2030)
- 14.3. Market Revenue, by Test Type (2017-2030)
- 14.4. Market Revenue, by End User (2017-2030)
- 14.5. Market Revenue, by Workflow (2017-2030)
- 14.5.1. Sample preparation market revenue, by type (2017-2030)
- 14.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Molecule Type (2017-2030)
- 15.3. Market Revenue, by Test Type (2017-2030)
- 15.4. Market Revenue, by End User (2017-2030)
- 15.5. Market Revenue, by Workflow (2017-2030)
- 15.5.1. Sample preparation market revenue, by type (2017-2030)
- 15.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Molecule Type (2017-2030)
- 16.3. Market Revenue, by Test Type (2017-2030)
- 16.4. Market Revenue, by End User (2017-2030)
- 16.5. Market Revenue, by Workflow (2017-2030)
- 16.5.1. Sample preparation market revenue, by type (2017-2030)
- 16.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Molecule Type (2017-2030)
- 17.3. Market Revenue, by Test Type (2017-2030)
- 17.4. Market Revenue, by End User (2017-2030)
- 17.5. Market Revenue, by Workflow (2017-2030)
- 17.5.1. Sample preparation market revenue, by type (2017-2030)
- 17.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Molecule Type (2017-2030)
- 18.3. Market Revenue, by Test Type (2017-2030)
- 18.4. Market Revenue, by End User (2017-2030)
- 18.5. Market Revenue, by Workflow (2017-2030)
- 18.5.1. Sample preparation market revenue, by type (2017-2030)
- 18.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Molecule Type (2017-2030)
- 19.3. Market Revenue, by Test Type (2017-2030)
- 19.4. Market Revenue, by End User (2017-2030)
- 19.5. Market Revenue, by Workflow (2017-2030)
- 19.5.1. Sample preparation market revenue, by type (2017-2030)
- 19.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Molecule Type (2017-2030)
- 20.3. Market Revenue, by Test Type (2017-2030)
- 20.4. Market Revenue, by End User (2017-2030)
- 20.5. Market Revenue, by Workflow (2017-2030)
- 20.5.1. Sample preparation market revenue, by type (2017-2030)
- 20.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Molecule Type (2017-2030)
- 21.3. Market Revenue, by Test Type (2017-2030)
- 21.4. Market Revenue, by End User (2017-2030)
- 21.5. Market Revenue, by Workflow (2017-2030)
- 21.5.1. Sample preparation market revenue, by type (2017-2030)
- 21.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Molecule Type (2017-2030)
- 22.3. Market Revenue, by Test Type (2017-2030)
- 22.4. Market Revenue, by End User (2017-2030)
- 22.5. Market Revenue, by Workflow (2017-2030)
- 22.5.1. Sample preparation market revenue, by type (2017-2030)
- 22.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Molecule Type (2017-2030)
- 23.3. Market Revenue, by Test Type (2017-2030)
- 23.4. Market Revenue, by End User (2017-2030)
- 23.5. Market Revenue, by Workflow (2017-2030)
- 23.5.1. Sample preparation market revenue, by type (2017-2030)
- 23.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Molecule Type (2017-2030)
- 24.3. Market Revenue, by Test Type (2017-2030)
- 24.4. Market Revenue, by End User (2017-2030)
- 24.5. Market Revenue, by Workflow (2017-2030)
- 24.5.1. Sample preparation market revenue, by type (2017-2030)
- 24.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Molecule Type (2017-2030)
- 25.3. Market Revenue, by Test Type (2017-2030)
- 25.4. Market Revenue, by End User (2017-2030)
- 25.5. Market Revenue, by Workflow (2017-2030)
- 25.5.1. Sample preparation market revenue, by type (2017-2030)
- 25.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Molecule Type (2017-2030)
- 26.3. Market Revenue, by Test Type (2017-2030)
- 26.4. Market Revenue, by End User (2017-2030)
- 26.5. Market Revenue, by Workflow (2017-2030)
- 26.5.1. Sample preparation market revenue, by type (2017-2030)
- 26.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Molecule Type (2017-2030)
- 27.3. Market Revenue, by Test Type (2017-2030)
- 27.4. Market Revenue, by End User (2017-2030)
- 27.5. Market Revenue, by Workflow (2017-2030)
- 27.5.1. Sample preparation market revenue, by type (2017-2030)
- 27.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Molecule Type (2017-2030)
- 28.3. Market Revenue, by Test Type (2017-2030)
- 28.4. Market Revenue, by End User (2017-2030)
- 28.5. Market Revenue, by Workflow (2017-2030)
- 28.5.1. Sample preparation market revenue, by type (2017-2030)
- 28.5.2. Sample analysis market revenue, by type (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Syneos Health
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Charles River Laboratories International Inc.
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Laboratory Corporation of America Holdings
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. ICON Plc
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. SGS Societe Generale de Surveillance SA
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Thermo Fisher Scientific Inc.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. IQVIA HOLDINGS INC.
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Parexel International Corporation
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.9. Bioneeds India Pvt. Ltd.
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.10. Medpace Holdings, Inc.
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
- 30.11. Intertek Group plc
- 30.11.1. Business overview
- 30.11.2. Product and service offerings
- 30.11.3. Key financial summary
- 30.12. Eurofins Scientific SE
- 30.12.1. Business overview
- 30.12.2. Product and service offerings
- 30.12.3. Key financial summary
- 30.13. WuXi AppTec
- 30.13.1. Business overview
- 30.13.2. Product and service offerings
- 30.13.3. Key financial summary
- 30.14. Pharmaron Beijing Co., Ltd.
- 30.14.1. Business overview
- 30.14.2. Product and service offerings
- 30.14.3. Key financial summary
- 30.15. KCAS Bioanalytical and Biomarker Services, LLC
- 30.15.1. Business overview
- 30.15.2. Product and service offerings
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.